Usher syndrome: conventional and innovative therapies

Testing a Dual AAV Gene Therapy Approach for the Treatment of Usher Syndrome 1F using Human Patient-derived Retinal Organoids – Joel Waters, Lions Eye Institute, Perth, Australia

Gene therapy for sensorineural deafness: the advent of the curative era – Saaid Safieddine, Institut de l’Audition, Paris, France

Towards optogenetic hearing restoration –Tobias Moser, Institute for Auditory Neuroscience, Göttingen, Germany

Human induced pluripotent stem cell-derived otic sensory progenitors for sensorineural hearing loss: a challenge in continuous progress – Azel Zine, Laboratoire Bio ingénierie et Nanosciences, Montpellier, France